Role of Ayurvedic medicines in Dadru
Phase 3
Not yet recruiting
- Conditions
- Health Condition 1: L303- Infective dermatitisHealth Condition 2: L08- Other local infections of skin andsubcutaneous tissue
- Registration Number
- CTRI/2022/06/043469
- Lead Sponsor
- ational Institute of ayurveda jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient willing to participate in clinical trial.
2.The patients of either sex having age between 18 - 60 years.
3.The patients having clinical signs and symptoms of Dadru Kushtha with special reference to Fungal Dermatophytosis.
Exclusion Criteria
1.Patients with long-term history of steroid (Internal and Topical) and cytotoxic treatment.
2.Patients having concomitant illness like uncontrolled Hypertension, Diabetes Mellitus, HIV, Malignancy, etc.
3.Patients having other associated skin disease like eczema, secondary bacterial infection, etc.
4.Patient participated in any clinical trial with in last six months.
5.Pregnant or lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in 12-item pruritus severity scale.Timepoint: 2 weeks and 4 weeks
- Secondary Outcome Measures
Name Time Method <br/ ><br>â?¢Changes in lab investigations, size of lesions and number of lesions. <br/ ><br>Timepoint: ONE AND HALF YEAR